InsidersTradesSigma
Follow the 에임드바이오 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 에임드바이오 has logged 16 insider filings. The latest transaction was reported on 5 February 2026 (Sale). Among the most active insiders: 인터베스트. All data is accessible without an account.
16
Insider Decl.
n/a
Thresholds
n/a
12 ops.
Buy Volume
n/a
3 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 February 2026
Declarations16 total
910,410 sharesKRXDART:20251222000374
10,590,823 sharesKRXDART:20251208000072
4,749,566 sharesKRXDART:20251205000210
16 of 16 declarations
About 에임드바이오
AimdBio is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.